NCT05941741 2026-03-18
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
Sun Yat-sen University
Phase 3 Recruiting
Clinical Trials
20 trialsNCT06029270 2026-03-18
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT06064097 2026-03-18
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT07459296 2026-03-16
Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
First Affiliated Hospital of Guangxi Medical University
Phase 3 Recruiting
NCT06239727 2026-03-06
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
Sun Yat-sen University
Phase 3 Recruiting
NCT06976190 2026-01-20
Magic-C002
Shanghai Miracogen Inc.
Phase 3 Recruiting
NCT06802835 2025-05-16
EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 1/2 Recruiting
NCT06886347 2025-03-20
Metastatic Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 1 Recruiting
NCT06851247 2025-02-28
GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.
Sun Yat-sen University
Phase 2 Recruiting
NCT06629597 2025-02-10
A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 3 Recruiting
NCT04544969 2025-01-28
Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
Sun Yat-sen University
Recruiting
NCT06323239 2024-08-20
SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Recruiting
NCT05979961 2024-08-06
Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Recruiting
NCT06019130 2024-05-16
NPC-Nivo
German Society for Pediatric Oncology and Hematology GPOH gGmbH
Phase 2 Recruiting
NCT06026878 2023-09-07
GNT Induction Treatment in Locally Advanced NPC
Air Force Military Medical University, China
Phase 3 Recruiting
NCT05854849 2023-05-11
Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC
Sun Yat-sen University
Phase 3 Recruiting
NCT05527470 2023-05-03
Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Guilin Medical University, China
Phase 3 Recruiting
NCT05717790 2023-02-08
Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma
Fourth Affiliated Hospital of Guangxi Medical University
Phase NA Recruiting
NCT04898374 2022-08-17
Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma
Kuwait Cancer Control Center
Phase 3 Recruiting
NCT05352321 2022-07-01
Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase NA Recruiting